Voloridge Investment Management
FATE icon

Voloridge Investment Management’s Fate Therapeutics FATE Stock Holding History

Voloridge Investment Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-63,903
Closed -$224K – 1240
2024
Q3 		$224K Sell
63,903
-38,392
-38% -$149K ﹤0.01% 1125
2024
Q2 		$336K Sell
102,295
-276,313
-73% -$1.21M ﹤0.01% 1143
2024
Q1 		$2.78M Buy
+378,608
New +$2.34M 0.01% 783
2023
Q3 		– Sell
-834,324
Closed -$3.97M – 1456
2023
Q2 		$3.97M Sell
834,324
-624,959
-43% -$3.45M 0.02% 751
2023
Q1 		$8.32M Buy
1,459,283
+928,247
+175% +$5.6M 0.04% 509
2022
Q4 		$5.36M Buy
531,036
+8,462
+2% +$159K 0.03% 622
2022
Q3 		$11.7M Buy
522,574
+44,421
+9% +$1.28M 0.06% 401
2022
Q2 		$11.8M Buy
478,153
+259,435
+119% +$7.16M 0.06% 392
2022
Q1 		$8.48M Sell
218,718
-51,402
-19% -$1.99M 0.05% 462
2021
Q4 		$15.8M Buy
270,120
+145,574
+117% +$8.25M 0.09% 327
2021
Q3 		$7.38M Buy
124,546
+114,447
+1,133% +$8.98M 0.05% 533
2021
Q2 		$876K Buy
+10,099
New +$814K 0.01% 1298
2021
Q1 		– Sell
-35,218
Closed -$3.2M – 1479
2020
Q4 		$3.2M Buy
35,218
+7,253
+26% +$450K 0.03% 584
2020
Q3 		$1.12M Buy
+27,965
New +$976K 0.01% 904
2020
Q2 		– Sell
-34,166
Closed -$759K – 1329
2020
Q1 		$759K Buy
+34,166
New +$864K 0.02% 592

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Voloridge Investment Management's FATE Position: Q4 2024 in Review

Voloridge Investment Management sold out of Fate Therapeutics (FATE) in Q4 2024, closing a stake of 63,903 shares — an estimated $224K sold.

Voloridge Investment Management first reported a position in FATE in Q1 2020 and held it in 15 quarters. The position peaked at $15.8M in Q4 2021. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2024.

  • Voloridge Investment Management reported no remaining Fate Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 63,903 Fate Therapeutics shares in Q4 2024, an estimated $224K.
  • Voloridge Investment Management first reported a position in Fate Therapeutics in Q1 2020 and held it in 15 quarters.
  • Voloridge Investment Management's Fate Therapeutics position peaked at $15.8M in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.